Dr Nathan Dormer
Director, Drug Product Development

About

Nathan Dormer, PhD, is Director, Drug Product Development at Adare Pharma, and was previously Vice-President of Research & Development at Orbis Biosciences until Orbis was acquired by Adare in 2020. He has a decade of experience developing a variety of controlled-release solutions using microsphere techniques. He received his BS in Chemical Engineering from The University of Kansas (Lawrence, KS, US) before completing his PhD in Bioengineering with Honors from The University of Kansas with NIH-sponsored training in drug delivery and protein stability. He has authored a number of publications and book chapters relating to microsphere encapsulation and has direct experience formulating dozens of active pharmaceutical ingredients.

Contributions

GI/ORAL

SINGLE-STEP FUNCTIONAL COATINGS FOR INCREASED EFFICIENCIES

In this article about oral drug innovation, Cory Berkland and Nathan Dormer focus on how enterics and reverse enterics are applied into dosage forms, and discuss the future of this class of drug formulation technology.

More contributions

GI/ORAL

THE EMERGENCE OF CONTROLLED-RELEASE POWDERS FOR ORAL ADMINISTRATION

Cory Berkland and Nathan Dormer look at what controlled-release powder delivery systems can offer, noting that a rising number of pharmaceutical companies and manufacturing organisations are incorporating controlled-release powder manufacturing to their portfolios.